rs142161862

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001379110.1(SLC9A6):​c.1287A>G​(p.Gln429Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,177,217 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000063 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000037 ( 0 hom. 12 hem. )

Consequence

SLC9A6
NM_001379110.1 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.69

Publications

1 publications found
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
SLC9A6 Gene-Disease associations (from GenCC):
  • Christianson syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant X-136022678-A-G is Benign according to our data. Variant chrX-136022678-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 207234.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.68 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000626 (7/111879) while in subpopulation NFE AF = 0.000132 (7/53196). AF 95% confidence interval is 0.0000615. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001379110.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC9A6
NM_001379110.1
MANE Select
c.1287A>Gp.Gln429Gln
synonymous
Exon 12 of 18NP_001366039.1
SLC9A6
NM_001438742.1
c.1443A>Gp.Gln481Gln
synonymous
Exon 11 of 17NP_001425671.1
SLC9A6
NM_001042537.2
c.1443A>Gp.Gln481Gln
synonymous
Exon 11 of 16NP_001036002.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC9A6
ENST00000630721.3
TSL:4 MANE Select
c.1287A>Gp.Gln429Gln
synonymous
Exon 12 of 18ENSP00000487486.2
SLC9A6
ENST00000370695.8
TSL:1
c.1443A>Gp.Gln481Gln
synonymous
Exon 11 of 16ENSP00000359729.4
SLC9A6
ENST00000370698.7
TSL:1
c.1347A>Gp.Gln449Gln
synonymous
Exon 11 of 16ENSP00000359732.3

Frequencies

GnomAD3 genomes
AF:
0.0000626
AC:
7
AN:
111879
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000491
AC:
9
AN:
183190
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000313
Gnomad NFE exome
AF:
0.0000489
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000366
AC:
39
AN:
1065338
Hom.:
0
Cov.:
25
AF XY:
0.0000359
AC XY:
12
AN XY:
334424
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25711
American (AMR)
AF:
0.00
AC:
0
AN:
34794
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18835
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29289
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53346
European-Finnish (FIN)
AF:
0.000102
AC:
4
AN:
39357
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4005
European-Non Finnish (NFE)
AF:
0.0000417
AC:
34
AN:
815404
Other (OTH)
AF:
0.0000224
AC:
1
AN:
44597
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000626
AC:
7
AN:
111879
Hom.:
0
Cov.:
22
AF XY:
0.0000587
AC XY:
2
AN XY:
34051
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30749
American (AMR)
AF:
0.00
AC:
0
AN:
10546
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2693
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6027
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.000132
AC:
7
AN:
53196
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 28, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC9A6: BP4, BP7, BS2

not specified Benign:1
Jun 22, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Christianson syndrome Benign:1
Nov 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
4.3
DANN
Benign
0.59
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142161862; hg19: chrX-135104837; COSMIC: COSV65788397; COSMIC: COSV65788397; API